-
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV TrialF Cosentino , CP Cannon , DZI Cherney et al. -
Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic AnalysisAL Beale, S Nanayakkara, L Segan et al.
-
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future DirectionsHsu JJ, Ziaeian B, Fonarow GC.
-
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF RegistriesKi Hong Choi Jin‐Oh Choi et al.
-
The year in cardiology: heart failure: The year in cardiology 2019JGF Cleland, AR Lyon, T McDonagh et al.
-
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection FractionJ Tromp, L Shen, PS Jhund et al.
-
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of AmericaDunlay SM, Givertz MM, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America.
-
Primary Prevention of Heart Failure in WomenMA Daubert, PS Douglas.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
